Free Trial
OTCMKTS:BFNH

BioForce Nanosciences 4/1/2024 Earnings Report

BioForce Nanosciences logo
$0.75 +0.13 (+20.99%)
As of 07/18/2025 03:48 PM Eastern

BioForce Nanosciences EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioForce Nanosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

BioForce Nanosciences Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

BioForce Nanosciences' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules.

Conference Call Resources

BioForce Nanosciences Earnings Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
BioForce Nanosciences Holdings, Inc. (BFNH)
BioForce Nanosciences Holdings Inc (BFNH)
BioForce Nanosciences Holdings Inc.
See More BioForce Nanosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioForce Nanosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioForce Nanosciences and other key companies, straight to your email.

About BioForce Nanosciences

BioForce Nanosciences (OTCMKTS:BFNH), Inc. (OTCMKTS:BFNH) is a U.S.-based developer and manufacturer of nanoscale tools and materials for research and industrial applications. Founded in 1998 as a university spin-off in Ames, Iowa, the company specializes in high-precision atomic force microscopy (AFM) probes and biolistic (“gene gun”) particle delivery systems. Its products are designed to meet the rigorous demands of academic, government and commercial research environments.

The company’s flagship product line includes silicon nitride and diamond-coated AFM probes engineered for high aspect-ratio imaging, enhanced durability and consistent performance. BioForce also offers the Nano eNabler®, a benchtop biolistic transfection device that enables researchers in life sciences, agriculture, cosmetics and biofuels to deliver DNA, RNA, proteins and other biomolecules into cells with micrometer-scale precision. In addition to catalog offerings, BioForce provides custom design services, small-scale manufacturing and technical support for specialized nanoscale applications.

BioForce Nanosciences serves a global customer base, distributing its products throughout North America, Europe and Asia via direct sales and authorized distributors. Its probes and delivery systems are employed in university laboratories, government research centers and leading pharmaceutical and biotech companies. The firm’s commitment to quality and innovation has made its AFM tips and biolistic instruments well regarded among nanoscale research communities worldwide.

Guided by a leadership team of seasoned nanotechnology and biotechnology professionals, BioForce continues to expand its product portfolio and advance next-generation research tools. The company has collaborated on grants and joint development projects with academic institutions and industrial partners, underscoring its focus on both scientific excellence and practical commercialization. With a strategic emphasis on innovation, BioForce Nanosciences aims to support breakthroughs in material science, molecular biology and related fields.

View BioForce Nanosciences Profile

More Earnings Resources from MarketBeat